Department of Surgery, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada.
Department of Surgical Oncology and Endocrine Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Ann Surg Oncol. 2019 Dec;26(13):4439-4444. doi: 10.1245/s10434-019-07618-y. Epub 2019 Oct 3.
In the current guidelines for differentiated thyroid cancer (DTC), computed tomography (CT) of the neck has a limited role. The authors hypothesized that adding CT to the workup of clinically low-risk DTC size 4 cm or smaller changes the surgical management for a portion of patients due to detection of clinically significant lymph node metastases not located by ultrasound of the neck.
A prospective cohort of DTC patients at an academic referral center between 2012 and 2016 was reviewed. All the patients with fine-needle aspiration cytopathology results suspicious for malignancy or malignant tumor (Bethesda category 5 or 6, respectively) underwent CT before surgery. Clinically low-risk DTC patients were selected if they had a tumor diameter of 4 cm or less and no evidence for local invasion or suspicious lymph nodes seen on ultrasound. Outcomes focused on alteration of the surgical plan based on CT and correlation with pathology.
The CT findings for 25 (22.5%) of 111 patients with clinically low-risk DTC led to a change in surgical management. Of these 25 patients, 16 (14.4% of the entire cohort) benefited due to the removal of clinically significant lymph node disease not seen on ultrasound. Categorization of the group that had a change in management showed that 6 (85.7%) of 7 lateral neck dissections and 10 (55.6%) of 18 central neck dissections (CND) harbored metastatic nodes larger than 2 mm.
In the group with clinically low-risk DTC, CT changed surgical management for a substantial number of the patients with clinically significant nodal disease not detected by ultrasound. This highlights the fact that in certain practice settings, adding CT to the preoperative staging may be favorable for the detection of nodal metastasis.
在当前分化型甲状腺癌(DTC)的指南中,颈部计算机断层扫描(CT)的作用有限。作者假设,对于临床低风险、直径 4cm 或更小的 DTC 患者,由于 CT 检测到了颈部超声未发现的具有临床意义的淋巴结转移,这部分患者的手术管理会发生改变。
回顾了 2012 年至 2016 年在学术转诊中心的一组 DTC 患者的前瞻性队列研究。所有细针抽吸细胞学检查结果为恶性或恶性肿瘤可疑(分别为 Bethesda 分类 5 或 6)的患者在手术前均行 CT 检查。如果肿瘤直径为 4cm 或更小,且超声未见局部侵犯或可疑淋巴结,选择临床低危 DTC 患者。主要结局是基于 CT 检查改变手术计划,并与病理结果相关联。
25 例(111 例临床低危 DTC 患者的 22.5%)患者的 CT 结果导致手术管理发生改变。在这 25 例患者中,16 例(整个队列的 14.4%)因超声未发现的具有临床意义的淋巴结疾病得到了获益。改变管理的分组显示,6 例(85.7%)侧颈部淋巴结清扫术和 10 例(55.6%)中央颈部淋巴结清扫术(CND)中存在大于 2mm 的转移性淋巴结。
在临床低危 DTC 患者中,CT 改变了大量临床淋巴结疾病未被超声发现的患者的手术管理。这突出表明,在某些临床环境下,在术前分期中增加 CT 可能有利于检测淋巴结转移。